Biotech Investor Acquires Rival's Assets Worth $284M
Biotechnology investor RTW Biotech Opportunities Ltd. said Tuesday that it has acquired the assets of its rival Arix Bioscience PLC, which are worth nearly $284 million excluding liabilities....To view the full article, register now.
Already a subscriber? Click here to view full article